CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Kowa Company Ltd. v. Apotex Inc.

1:14-cv-01264

Overview

Case Number 1:14-cv-01264
Filing Date 2014-10-02
Status Terminated
Termination Date 2015-02-20
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Apotex Corp. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Kowa Company Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Nissan Chemical Industries Ltd. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Kowa Pharmaceuticals America Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Interested Party

Apotex Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 17 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts Counterparts in force
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (17): πŸ‡ͺπŸ‡Ί Europe πŸ‡ΊπŸ‡Έ US 🌐 PCT
Parallel Proceedings Across Jurisdictions (0 found):

No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.

Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US8557993
Crystalline forms of pitavastatin calcium
Filed: 2012-10-31
Issued: 2013-10-15
Active (5.9 yrs remaining)
Expires: 2032-10-31

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Active Threat

Active Threat β€” Patent is within enforceable statutory term; injunctive relief viable.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).

Docket Entries

(11 total)
Pleading / Complaint

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600292.) - filed by Kowa Pharmaceuticals America Inc., Kowa Company Ltd., Nissan Chemical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Main Document 1 replaced on 10/3/2014) (dmp, ). (Entered: 10/02/2014)

Entry #1 • 2014-10-02
1
Pleading / Complaint

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600292.) - filed by Kowa Pharmaceuticals America Inc., Kowa Company Ltd., Nissan Chemical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Main Document 1 replaced on 10/3/2014) (dmp, ). (Entered: 10/02/2014)

Entry #1 • 2014-10-02
2
Pleading / Complaint

COMPLAINT filed against Apotex Corp., Apotex Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 311-1600292.) - filed by Kowa Pharmaceuticals America Inc., Kowa Company Ltd., Nissan Chemical Industries Ltd.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(dmp, ) (Main Document 1 replaced on 10/3/2014) (dmp, ). (Entered: 10/02/2014)

Entry #1 • 2014-10-02
2

Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (dmp, ) (Entered: 10/02/2014)

Entry #2 • 2014-10-02
1

Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 08/21/2014. Date of Expiration of Patent: 02/02/2024.Thirty Month Stay Deadline: 2/21/2017. (dmp, ) (Entered: 10/02/2014)

Entry #3 • 2014-10-02
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc